Myocardial deletion of transcription factor CHF1/Hey2 results in altered myocyte action potential and mild conduction system expansion but does not alter conduction system function or promote spontaneous arrhythmias
Matthew E. Hartman(University of Washington), Michael T. Chin(Tufts Medical Center), Michael A. Laflamme(University Health Network), Yonggang Liu(Southwest University of Science and Technology), Chad S. Weldy(University of Washington), Wei‐Ming Chien(University of Washington), Weizhong Zhu(Nantong University), Glenn I. Fishman(New York University)
Cited by 21
Related Papers
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
|New England Journal of Medicine|2020|1.1k
ST-Segment Elevation in Patients with Covid-19 — A Case Series
|New England Journal of Medicine|2020|858
Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies
|Nature Medicine|2014|843
Conduction Slowing and Sudden Arrhythmic Death in Mice With Cardiac-Restricted Inactivation of Connexin43
|Circulation Research|2001|686
Sudden Cardiac Death Prediction and Prevention
|Circulation|2010|608